Mechanism of the Covalent Inhibition of Human Transmembrane Protease Serine 2 as an Original Antiviral Strategy.


Journal

The journal of physical chemistry. B
ISSN: 1520-5207
Titre abrégé: J Phys Chem B
Pays: United States
ID NLM: 101157530

Informations de publication

Date de publication:
20 07 2023
Historique:
medline: 21 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

The Transmembrane Protease Serine 2 (TMPRSS2) is a human enzyme which is involved in the maturation and post-translation of different proteins. In addition to being overexpressed in cancer cells, TMPRSS2 plays a further fundamental role in favoring viral infections by allowing the fusion of the virus envelope with the cellular membrane, notably in SARS-CoV-2. In this contribution, we resort to multiscale molecular modeling to unravel the structural and dynamical features of TMPRSS2 and its interaction with a model lipid bilayer. Furthermore, we shed light on the mechanism of action of a potential inhibitor (nafamostat), determining the free-energy profile associated with the inhibition reaction and showing the facile poisoning of the enzyme. Our study, while providing the first atomistically resolved mechanism of TMPRSS2 inhibition, is also fundamental in furnishing a solid framework for further rational design targeting transmembrane proteases in a host-directed antiviral strategy.

Identifiants

pubmed: 37428676
doi: 10.1021/acs.jpcb.3c02910
doi:

Substances chimiques

Antiviral Agents 0
Serine 452VLY9402

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6287-6295

Auteurs

Angelo Spinello (A)

Department of Biological, Chemical and Pharmaceutical Sciences, University of Palermo, 90126 Palermo, Italy.

Luisa D'Anna (L)

Department of Biological, Chemical and Pharmaceutical Sciences, University of Palermo, 90126 Palermo, Italy.

Emmanuelle Bignon (E)

Université de Lorraine and CNRS, UMR 7019 LPCT, F-54000 Nancy, France.

Tom Miclot (T)

Department of Biological, Chemical and Pharmaceutical Sciences, University of Palermo, 90126 Palermo, Italy.
Université de Lorraine and CNRS, UMR 7019 LPCT, F-54000 Nancy, France.

Stéphanie Grandemange (S)

Université de Lorraine and CNRS, UMR 7039 CRAN, F-54000 Nancy, France.

Alessio Terenzi (A)

Department of Biological, Chemical and Pharmaceutical Sciences, University of Palermo, 90126 Palermo, Italy.

Giampaolo Barone (G)

Department of Biological, Chemical and Pharmaceutical Sciences, University of Palermo, 90126 Palermo, Italy.

Florent Barbault (F)

Université Paris Cité and CNRS, ITODYS, F-75006 Paris, France.

Antonio Monari (A)

Université Paris Cité and CNRS, ITODYS, F-75006 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH